KRSNAA

Krsnaa Diagnostics Ltd.

NSE: KRSNAA

BSE: 543328

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Service Provider

571.00-1.9 (-0.33%)

3 Jul, 3:30 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

79.0 / 100

Value Score

79.4 / 100

Price Momentum Score

25.7 / 100

QVM Score

71.4 / 100

Key Metrics

Market Cap

1858.43

P/E (TTM)

18.32

P/B

1.90

P/S (TTM)

2.40

EV/EBITDA

9.44

CAPE (5Y)

25.15

ROE (TTM)

10.89

ROCE (TTM)

9.34

ROA (TTM)

6.53

Avg 3Y ROE

9.13

Earnings 3Y CAGR

16.98

Sales 3Y CAGR

16.63

Sales 5Y CAGR

14.28

Debt/Equity

0.55

Consensus TP

833.00

Strong Buy %

33.33

Promoter Holding

27.11

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Krsnaa Diagnostics Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 18.32 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -33.89%

What is P/E Ratio?

Median: 27.71

Value 18.32

6.282638.46

Moderate ROE but improving trend

The company reported moderate ROE of 10.89% for 12-month ended 31 Mar 2026 but ROE improved by 172 bps from 1 year ago

What is ROE (FY)?

High and improving operating margin

The company reported strong operating margin of 15.71% for 12-month ended 31 Mar 2026 and operating margin improved by 150 bps from 1 year ago

What is Operating profit margin?

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 31.09% for 12-month ended 31 Mar 2026 and the growth was 29.95 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Consistently pays dividend

The company has not missed dividend payments once in the last 4 financial years

What is Dividend streak?

Negative

Weak price momentum

Price Momentum score of 25.7 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

25.7 / 100

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -11.42% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of 7.75% for 12-month ended 31 Mar 2026 and the growth was 5.81 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 13.56

Value 7.75

-97.35238.8

Low dividend yield

The company has a low dividend yield of 0.48%

What is Dividend yield?

Neutral

Low Debt to Equity but increasing

The company has low Debt to Equity of 0.55 as on 31 Mar 2026 but Debt to Equity increased by 0.32 in the last 1 year

What is Debt to Equity?

Company's earnings are of moderate quality

Earnings quality score of 46.9 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

46.9 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Krsnaa Diagnostics Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Krsnaa Diagnostics Ltd. Shareholding Pattern

Quarterly breakdown of Krsnaa Diagnostics Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	27.38	27.38	27.38	27.38	27.80	27.80	27.80	27.80	27.80	27.03	27.03	27.17	27.17	27.24	27.24	27.11	27.11	27.11	27.11
Indian Promoter	27.38	27.38	27.38	27.38	27.80	27.80	27.80	27.80	27.80	27.03	27.03	27.17	27.17	27.24	27.24	27.11	27.11	27.11	27.11
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	36.16	34.58	33.13	31.63	24.49	23.55	21.87	25.46	22.41	20.02	18.71	18.59	19.49	18.50	17.81	17.64	18.63	18.03	17.80
Mutual Funds / UTI	9.61	11.22	10.56	10.46	10.99	11.58	12.00	13.26	13.99	11.89	11.05	11.91	11.56	9.82	9.36	9.63	10.46	10.15	10.17
FI/Bank/Insurance	0.03	0.00	0.00	0.01	9.43	7.83	6.49	6.51	4.66	4.46	4.09	2.86	2.86	2.95	2.95	2.69	2.67	2.67	2.67
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	6.00	10.82	4.49	4.27	4.06	4.14	3.38	5.69	3.68	3.44	3.34	3.33	3.63	4.04	3.55	3.40	3.66	4.17	3.91
Other Institutions	20.52	12.54	35.95	33.76	0.01	0.00	0.01	0.00	0.08	0.24	0.23	0.49	1.44	1.69	1.95	1.92	1.83	1.03	1.05
Non-Institution	36.45	38.04	39.49	40.98	47.72	48.66	50.33	46.74	49.79	52.95	54.26	54.24	53.34	54.27	54.94	55.25	54.26	54.85	55.08
Bodies Corporate	18.81	18.88	19.25	19.52	20.23	19.66	19.98	19.97	20.80	20.52	21.65	21.67	21.05	21.03	21.53	21.80	22.28	22.43	21.93
Others (incl. Retail) No. of shareholders	17.64 75,304	19.16 74,820	20.24 71,234	21.46 70,040	27.49 69,797	29.00 68,439	30.35 66,859	26.77 61,998	28.99 60,389	32.43 56,913	32.61 56,129	32.57 55,604	32.29 53,178	33.24 52,405	33.41 53,034	33.45 53,731	31.98 51,557	32.42 51,788	33.15 52,451

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Krsnaa Diagnostics Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Krsna Diagnostics Mumbai Private Limited Promoter Group	December-2024	Market Purchase (Acquisition) 31st Dec 2024	2.30 %	₹ 870.89	22.93 k	₹ 2.00 cr
KRSNA DIAGNOSTICS MUMBAI PRIVATE LIMITED Promoter Group	June-2024	Market Purchase (Acquisition) 6th Jun 2024	2.16 %	₹ 540.86	45.00 k	₹ 2.43 cr
Phi Capital Trust – Phi Capital Growth Fund – 1 Connected Person	February-2022	Market Purchase (Acquisition) 21st Feb 2022	15.82 %	₹ 604.94	10.00 k	₹ 60.49 lac
Phi Capital Trust – Phi Capital Growth Fund – 1 Connected Person	February-2022	Market Purchase (Acquisition) 21st Feb 2022	15.85 %	₹ 603.25	7.70 k	₹ 46.45 lac
Phi Capital Trust – Phi Capital Growth Fund – 1 Connected Person	February-2022	Market Purchase (Acquisition) 18th Feb 2022	15.77 %	₹ 619.92	5.29 k	₹ 32.78 lac
Phi Capital Trust – Phi Capital Growth Fund – 1 Connected Person	February-2022	Market Purchase (Acquisition) 18th Feb 2022	15.79 %	₹ 615.16	10.00 k	₹ 61.52 lac
Phi Capital Trust – Phi Capital Growth Fund – 1 Connected Person	February-2022	Market Purchase (Acquisition) 16th Feb 2022	15.67 %	₹ 643.43	7.16 k	₹ 46.06 lac
Phi Capital Trust – Phi Capital Growth Fund – 1 Connected Person	February-2022	Market Purchase (Acquisition) 16th Feb 2022	15.69 %	₹ 640.73	25.00 k	₹ 1.60 cr
Phi Capital Trust – Phi Capital Growth Fund – 1 Connected Person	February-2022	Market Purchase (Acquisition) 10th Feb 2022	15.50 %	₹ 652.09	1.78 k	₹ 11.61 lac
Phi Capital Trust – Phi Capital Growth Fund – 1 Connected Person	February-2022	Market Purchase (Acquisition) 10th Feb 2022	15.51 %	₹ 658.80	50.00 k	₹ 3.29 cr

Corporate Actions

History of Krsnaa Diagnostics Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 2.75/share
Record date: 12th Sep 2025Ex-date: 12th Sep 2025
Announced on: 12th May 2025
Dividend₹ 2.50/share
Record date: 13th Sep 2024Ex-date: 13th Sep 2024
Announced on: 19th May 2024
Dividend₹ 2.75/share
Record date: 15th Sep 2023Ex-date: 15th Sep 2023
Announced on: 27th May 2023
Dividend₹ 2.50/share
Record date: 16th Sep 2022Ex-date: 15th Sep 2022
Announced on: 30th May 2022

Company Profile

Overview of Krsnaa Diagnostics Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Krsnaa Diagnostics Limited is engaged in the business of providing diagnostic services primarily in relation to pathology investigation, radiology investigation, and tele reporting. The Company’s services include pathology, X-Ray and computed tomography (CT) scans, magnetic resonance imaging (MRI), ...

Key personnel

Mr. Mitesh Dave

Group Chief Executive Officer

Mr. Chandra Prakash Singh

Interim Chief Financial Officer

Mr. Sujoy Sudipta Bose

Company Secretary, Compliance Officer

Mr. Rajendra Khivraj MuthaD

Chairman and Whole Time Director

Mr. Yash Prithviraj MuthaD

Managing Director, Executive Director

Ms. Pallavi Shantilal BhatevaraD

Whole Time Director

Mr. Prem PradeepD

Nominee Director

Mr. Chetan Rameshchandra DesaiD

Non-Executive Independent Director

View all

Incorporated on

22 Dec 2010

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

16 Aug 2021

Free Float

1,76,18,879

Website

https://krsnaadiagnostics.com/

Phone no.

+912046954695

Address

S. No. 243/A, Hissa No. 6, CTS No. 4519, 4519/1 Near Chinchwad Station, Chinchwad, Haveli, , 411019, India

Frequently Asked Questions

What is the current share price of Krsnaa Diagnostics Ltd.?

The current share price of Krsnaa Diagnostics Ltd. is ₹ 571.00 as of 3 Jul 2026.

What is the market capitalisation of Krsnaa Diagnostics Ltd.?

The market capitalisation of Krsnaa Diagnostics Ltd. stands at ₹ 1,858.43 Cr.

What is the PE ratio of Krsnaa Diagnostics Ltd.?

The Price-to-Earnings (PE) ratio of Krsnaa Diagnostics Ltd. is 18.32 as of the latest trailing twelve months data.

What is the ROE and ROCE of Krsnaa Diagnostics Ltd.?

Krsnaa Diagnostics Ltd. has a Return on Equity (ROE) of 10.89% and a Return on Capital Employed (ROCE) of 9.34% as per the latest financial reports.

What is the 52-week high and low of Krsnaa Diagnostics Ltd.?

The 52-week high of Krsnaa Diagnostics Ltd. is - and the 52-week low is -.

What is the dividend yield of Krsnaa Diagnostics Ltd.?

The dividend yield of Krsnaa Diagnostics Ltd. is 0.48% based on the current market price.

What is the FII and DII holding in Krsnaa Diagnostics Ltd.?

Foreign Institutional Investors (FII) hold 3.91%, Domestic Institutional Investors (DII) hold 12.84% and retail/public investors hold 33.15% of Krsnaa Diagnostics Ltd. shares.

What sector does Krsnaa Diagnostics Ltd. belong to?

Krsnaa Diagnostics Ltd. operates in the Healthcare sector. 66.67% of analysts have a Buy or Strong Buy rating on Krsnaa Diagnostics Ltd. with a consensus target price of ₹ 833.00, implying 45.4% upside from current levels.

What is the beta of Krsnaa Diagnostics Ltd.?

The beta of Krsnaa Diagnostics Ltd. is 0.86, indicating its price volatility relative to the broader market. Over the past 1 year, Krsnaa Diagnostics Ltd. has delivered an absolute return of -17.98%.

What is the RSI of Krsnaa Diagnostics Ltd.?

The 14-day Relative Strength Index (RSI) of Krsnaa Diagnostics Ltd. is 65.87, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Krsnaa Diagnostics Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Krsnaa Diagnostics Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile